Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
Authors:
Open Access
- 7 March 2020
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 9 (9) , 3033-3042
Abstract
Febrile neutropenia (FN) is a critical complication of chemotherapy associated with increased in‐hospital mortality. However, associations with increased mortality and intensive care unit (ICU) admissions during longer follow‐up are not established. Patients treated with standard first‐line chemotherapy for solid cancers at Rigshospitalet, Denmark in 2010‐2016 were included. Incidence rate ratios (IRR) of all‐cause, infectious and cardiovascular mortality, and ICU admissions after FN were analyzed by Poisson regression. Risk factors at the time of FN were analyzed in the subpopulation of patients with FN; all‐cause mortality was further stratified by the time periods 0‐30, 31‐365, and 366+ days after FN. We included 9018 patients with gastric (14.4%) and breast (13.1%) cancer being the most common, 51.2% had locally advanced or disseminated disease and the patients had a median Charlson Comorbidity Index score of 0 (interquartile range, 0‐0). During follow‐up, 845 (9.4%) experienced FN and 4483 (49.7%) died during 18 775 person‐years of follow‐up. After adjustment, FN was associated with increased risk of all‐cause mortality, infectious mortality, and ICU admissions with IRRs of 1.39 (95% CI, 1.24‐1.56), 1.94 (95% CI, 1.43‐2.62), and 2.28 (95% CI, 1.60‐3.24). Among those with FN, having a positive blood culture and low lymphocytes were associated with excess risk of death and ICU admissions (predominantly the first 30 days after FN), while elevated C‐reactive protein and low hemoglobin predicted mortality the first year after FN. The risk of death varied according to the time since FN; adjusted IRR per additional risk factor present for the time periods 0‐30, 31‐365, and 366+ days after FN were 2.00 (95% CI, 1.45‐2.75), 1.36 (95% CI, 1.17‐1.57), and 1.17 (95% CI, 0.98‐1.41). FN was associated with increased mortality and risk of ICU admissions. An objectively identifiable subgroup of patients among those with FN carried this excess risk.Keywords
Funding Information
- Kræftens Bekæmpelse (R134‐A8436‐15‐S42)
- Danmarks Grundforskningsfond (126)
This publication has 33 references indexed in Scilit:
- Deviations From Guideline-Based Therapy for Febrile Neutropenia in Cancer Patients and Their Effect on OutcomesJAMA Internal Medicine, 2013
- Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyCochrane Database of Systematic Reviews, 2012
- Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysisBMC Cancer, 2011
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The Danish Register of Causes of DeathScandinavian Journal of Public Health, 2011
- The Danish Civil Registration SystemScandinavian Journal of Public Health, 2011
- Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort studyBMC Infectious Diseases, 2011
- Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisBMC Infectious Diseases, 2011
- Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropeniaSupportive Care in Cancer, 2010
- Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studySupportive Care in Cancer, 2008